With 20 years of experience in health policy, Paul Heldman specializes in translating legislative developments and policy changes – specifically for government health insurance programs, the FDA, pharmaceuticals, medical devices, US health spending, healthcare legislation, and national elections. Prior to joining Nephron, Paul co-cofounded Heldman Simpson Partners LLC, and ran the healthcare team at Potomac Research Group. Paul previously spent a combined eight years at Citigroup Investment Research and Schwab Soundview Washington Research Group.